Karfa S, Gopal R, Nadkarni J S
Division of Laboratory Medicine, Tata Memorial Hospital, Parel, Bombay, India.
Med Oncol Tumor Pharmacother. 1990;7(4):265-72. doi: 10.1007/BF02987105.
This study examines the immunophenotypic profiles in both pretreated and treated CLL patients which could be useful from the prognosis point of view. Patients suffering from B CLL and having IgG markers were relatively more aggressive than cells bearing IgM phenotypes. Male predominance is observed in male/female ratio in this disease. B CLL showed heterogeneity by showing reactivity against various T cell markers such as CD5 (present on mature T cells) and also CD4 (T helper/inducer), CD8 (T suppressor/cytotoxic) and a very high percentage of Ia (HLA-DR). The proliferative response to cells to stimulation with PHA and PWM indicated that there is a primary defect in the capacity of these small lymphocytes to undergo a proliferative response due to an intrinsic defect in the B lymphocytes. This study also reflects a maturation arrest in the later developmental stage of B lymphopoiesis. The three findings which are novel are the difference in prognosis between IgG-IgM and IgG, the changes in T cell subsets and the mitogenic response.
本研究检测了初治和经治慢性淋巴细胞白血病(CLL)患者的免疫表型特征,从预后角度来看这些特征可能有用。患有B细胞慢性淋巴细胞白血病且有IgG标志物的患者比带有IgM表型的细胞相对更具侵袭性。在这种疾病中,观察到男性/女性比例中男性占主导。B细胞慢性淋巴细胞白血病表现出异质性,表现为对各种T细胞标志物如CD5(存在于成熟T细胞上)以及CD4(T辅助/诱导细胞)、CD8(T抑制/细胞毒性细胞)和很高比例的Ia(HLA-DR)有反应。细胞对PHA和PWM刺激的增殖反应表明,由于B淋巴细胞存在内在缺陷,这些小淋巴细胞进行增殖反应的能力存在原发性缺陷。本研究还反映了B淋巴细胞生成后期发育阶段的成熟停滞。三项新发现是IgG-IgM和IgG之间的预后差异、T细胞亚群的变化以及促有丝分裂反应。